Tuesday, 22 December 2020 08:00 AM
Product Announcements
"TestTheTeam" is a convenient, cost effective test kit for your business or family
SAN DIEGO, CA / ACCESSWIRE / December 22, 2020 / BioSpyder Technologies, Inc. is announcing it is selling COVID-19 surveillance screening kits to businesses and consumers via its new ecommerce site testtheteam.com (live on Tuesday, December 22). The service, which utilizes the BioSpyder TempO-SPan technology, aims to relieve the pressure on America's COVID-19 testing infrastructure by offering an option that will screen four people at a time for only $39.99 (plus shipping and handling).
The kit comprises of four saliva collection tubes that contain mouthwash. The consumer will gargle with the mouthwash, spit back into the tube and send it back to BioSpyder for testing. The mouthwash inactivates virus that may be present so it will be safe to handle. Once BioSpyder receives the samples, customers will be notified within 24-48 hours whether COVID-19 virus was detected for the team as a group. Individual results will not be provided. This allows an organization or household to screen a group of people at one time safely, accurately, and more affordably giving everyone peace of mind.
"If America is to get back to work, we need to do all that we can to encourage widespread, regular affordable screening," said BioSpyder CEO Joel McComb, "TestTheTeam is an effective solution for groups of people to have more confidence in their interactions, whether your team is family, co-workers, or a social group."
All state and federal COVID-19 guidelines should still be followed regardless of the test outcome. BioSpyder has been developing the TempO-SPan COVID-19 test since early this year and it has been evaluated by leading clinical laboratories in the U.S. and the U.K.
Media Contacts
Joice Truban Curry - 619-540-6611
Sean Curry - 858-449-6282
About BioSpyder Technologies, Inc.
BioSpyder Technologies is based in Carlsbad, CA. and is a privately held company funded by government grants, contracts and sales revenue. BioSpyder is the developer of TempO-Seq®. The company markets kits and services which include optional custom content and/or attenuation of any set of genes, any variant or mutation, and any species. BioClavis is a Glasgow-based personalized diagnostics spin-out of BioSpyder developing services based on TempO-Seq. BioSpyder was founded by veteran molecular biology executives Joel McComb, Joanne Yeakley, Ph.D., and Bruce Seligmann, Ph.D., in 2011. More information about BioSpyder Technologies Inc. is available at www.biospyder.com, BioClavis at www.bioclavis.co.uk, and TestTheTeam.com.
SOURCE: BioSpyder Technologies, Inc.